Outcomes of Orthopaedic Surgery Using Gait Laboratory Versus Observational Gait Analysis in Children With Cerebral Palsy
Primary Purpose
Cerebral Palsy
Status
Active
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Routine Observational Analysis (prior to procedure)
Routine Observational analysis supplemented with Gait Lab Information (prior to procedure)
Sponsored by
About this trial
This is an interventional treatment trial for Cerebral Palsy focused on measuring Pediatrics, Cerebral Palsy, Gait Analysis, Orthopedic Surgery
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of spastic cerebral palsy.
- Age 6 to 15 years at the time of the initial assessment.
- Gross Motor Function Classification System (GMFCS) levels II or III (demonstrable independent ambulatory potential with or without orthotics/assist devices).
- Patients have been referred for assessment and treatment of gait abnormality.
- Patients have a gait abnormality interfering with their physical function.
- Patients are candidates for orthopaedic surgery including soft tissue and/or bony procedures involving at least 2 levels, in one or both lower extremities (e.g. knee & ankle).
- Patients must be able to undergo instrumented gait analysis in a motion laboratory.
Exclusion Criteria:
- Presence of dystonia, athetosis, or mixed tone abnormalities.
- History of orthopaedic lower extremity procedures within the previous 2 years.
- Patients who have had previous gait laboratory analysis that has been seen by the treating surgeon.
- Patients who will be unable to return for the required follow up visits/gait analysis.
Sites / Locations
- Glenrose Rehabilitation Hospital
- British Columbia's Children's Hospital
- Erinoak Centre
- Grandview Children's Rehabilitation Centre
- Bloorview Kids Rehab
- The Hospital for Sick Children
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Group A (standard pre-operative analysis)
Group B (additional pre-operative analysis)
Arm Description
Outcomes
Primary Outcome Measures
General Effect Size of Secondary Outcomes
The final primary and secondary outcome measures will be chosen based on responsiveness and their effect sizes used to calculate sample size for a future definitive trial.
Secondary Outcome Measures
Gross Motor Function Measure (GMFM-66)
A well validated condition specific clinical measure to evaluate change in motor function in children with cerebral palsy
Pediatric Outcomes Data Collection Instrument(PODCI)
A generic measure of musculoskeletal functional health outcomes in children and adolescents
Gillette Functional Assessment Questionnaire (FAQ)
A validated condition specific functional walking scale developed for children with cerebral palsy
Functional Mobility Scale (FMS)
Developed to measure functional mobility of a child in three different environments (home, school, and the wider community).
Activity Scale for Kids (ASK)
A reliable and valid, self-report measure of childhood physical disability.
Gillette Gait (Normalcy) Index (GGI)
Quantifies the magnitude of gait deviation from normal
Gait Parameters
Gait velocity; Stride length; O2 consumption & O2 Cost during walking
Full Information
NCT ID
NCT00419432
First Posted
January 5, 2007
Last Updated
February 9, 2021
Sponsor
The Hospital for Sick Children
1. Study Identification
Unique Protocol Identification Number
NCT00419432
Brief Title
Outcomes of Orthopaedic Surgery Using Gait Laboratory Versus Observational Gait Analysis in Children With Cerebral Palsy
Official Title
Functional Outcomes Following Orthopaedic Surgery Based on Gait Laboratory Versus Observational Gait Analysis in Ambulatory Children With Cerebral Palsy: A Multi-center Randomized Controlled Trial.
Study Type
Interventional
2. Study Status
Record Verification Date
February 2021
Overall Recruitment Status
Active, not recruiting
Study Start Date
January 2007 (undefined)
Primary Completion Date
August 2019 (Actual)
Study Completion Date
December 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hospital for Sick Children
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this pilot trial is to determine whether the addition of gait laboratory analysis for surgical decision making, compared with the use of observational analysis alone, results in improved functional outcomes in ambulatory children with cerebral palsy undergoing multi-level lower extremity orthopaedic surgery.
Detailed Description
Children with cerebral palsy, who are ambulatory, have an inefficient gait often associated with functional disability. Many of these children are candidates for orthopaedic surgery, which includes multi-level soft tissue and bony procedures. Pre-operative planning is based on the physical examination and visual (observational) analysis of the child's gait. In some centres, patients undergo additional gait analysis in a motion laboratory. While gait laboratory analysis is accepted as an important research tool, there is controversy about its clinical utility in decision making for the surgical management of this population. To date, no clinical trials have been undertaken to answer this question, and the appropriate clinical utilization of this technology is yet to be established. The consequence of this uncertainty is that ambulatory children with cerebral palsy are either being deprived of a useful assessment tool in some centres, or alternatively they are being subjected to an unnecessary evaluation that is both expensive and time consuming in other centres. A multi-centre randomized trial will provide evidence to support or refute the need for gait laboratory analysis for surgical decision-making for this population. This pilot randomized controlled trial in four sites will assess the feasibility of, and provide the template for the design and conduct of the definitive larger multi-centred trial to extend its generalizability across North America and other jurisdictions. The specific objectives include:
Establish the feasibility of implementing the randomized trial study design in multiple centres
Estimate recruitment rates and timelines
Establish responsiveness of outcome measures to finalize the primary & secondary outcomes
Estimate effect sizes of functional outcomes for sample size calculations
Establish data management system (web-based database) for definitive multi-centre study.
Assess feasibility, reliability and face validity of pilot health economic data forms to include health economic evaluation in the future definitive multi-centre trial.
Secondary objectives include:
Does the addition of gait analysis alter surgical decisions made from video observation alone, when performed in the setting of this pilot trial?
Evaluate the consistency of the surgical decision making: intra- & inter rater reliability
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cerebral Palsy
Keywords
Pediatrics, Cerebral Palsy, Gait Analysis, Orthopedic Surgery
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group A (standard pre-operative analysis)
Arm Type
Active Comparator
Arm Title
Group B (additional pre-operative analysis)
Arm Type
Experimental
Intervention Type
Other
Intervention Name(s)
Routine Observational Analysis (prior to procedure)
Intervention Description
Controls will undergo the standard orthopaedic surgery using the information from the physical examination and observational analysis of the gait alone.
Intervention Type
Other
Intervention Name(s)
Routine Observational analysis supplemented with Gait Lab Information (prior to procedure)
Intervention Description
This experimental group will undergo standard orthopaedic surgery using the information from the physical examination, observational AND the gait laboratory analysis data
Primary Outcome Measure Information:
Title
General Effect Size of Secondary Outcomes
Description
The final primary and secondary outcome measures will be chosen based on responsiveness and their effect sizes used to calculate sample size for a future definitive trial.
Time Frame
Post Study
Secondary Outcome Measure Information:
Title
Gross Motor Function Measure (GMFM-66)
Description
A well validated condition specific clinical measure to evaluate change in motor function in children with cerebral palsy
Time Frame
Baseline, 6, 12, 24 months follow up
Title
Pediatric Outcomes Data Collection Instrument(PODCI)
Description
A generic measure of musculoskeletal functional health outcomes in children and adolescents
Time Frame
Baseline, 6, 12, 24 months follow up
Title
Gillette Functional Assessment Questionnaire (FAQ)
Description
A validated condition specific functional walking scale developed for children with cerebral palsy
Time Frame
Baseline, 6, 12, 24 months follow up
Title
Functional Mobility Scale (FMS)
Description
Developed to measure functional mobility of a child in three different environments (home, school, and the wider community).
Time Frame
Baseline, 6, 12, 24 months follow up
Title
Activity Scale for Kids (ASK)
Description
A reliable and valid, self-report measure of childhood physical disability.
Time Frame
Baseline, 6, 12, 24 months follow up
Title
Gillette Gait (Normalcy) Index (GGI)
Description
Quantifies the magnitude of gait deviation from normal
Time Frame
Baseline, 6, 12, 24 months follow up
Title
Gait Parameters
Description
Gait velocity; Stride length; O2 consumption & O2 Cost during walking
Time Frame
Baseline, 12-, 24-months follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Diagnosis of spastic cerebral palsy.
Age 6 to 15 years at the time of the initial assessment.
Gross Motor Function Classification System (GMFCS) levels II or III (demonstrable independent ambulatory potential with or without orthotics/assist devices).
Patients have been referred for assessment and treatment of gait abnormality.
Patients have a gait abnormality interfering with their physical function.
Patients are candidates for orthopaedic surgery including soft tissue and/or bony procedures involving at least 2 levels, in one or both lower extremities (e.g. knee & ankle).
Patients must be able to undergo instrumented gait analysis in a motion laboratory.
Exclusion Criteria:
Presence of dystonia, athetosis, or mixed tone abnormalities.
History of orthopaedic lower extremity procedures within the previous 2 years.
Patients who have had previous gait laboratory analysis that has been seen by the treating surgeon.
Patients who will be unable to return for the required follow up visits/gait analysis.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Unni Narayanan, MBBS, MSc, FRCSC
Organizational Affiliation
The Hospital for Sick Children, Toronto Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
Glenrose Rehabilitation Hospital
City
Edmonton
State/Province
Alberta
Country
Canada
Facility Name
British Columbia's Children's Hospital
City
Vancouver
State/Province
British Columbia
Country
Canada
Facility Name
Erinoak Centre
City
Mississauga
State/Province
Ontario
ZIP/Postal Code
L5L 2M5
Country
Canada
Facility Name
Grandview Children's Rehabilitation Centre
City
Oshawa
State/Province
Ontario
ZIP/Postal Code
L1H 7K6
Country
Canada
Facility Name
Bloorview Kids Rehab
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4G 1R8
Country
Canada
Facility Name
The Hospital for Sick Children
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X8
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Outcomes of Orthopaedic Surgery Using Gait Laboratory Versus Observational Gait Analysis in Children With Cerebral Palsy
We'll reach out to this number within 24 hrs